Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Sunitinib does not accelerate tumor growth in patients with metastatic renal cell carcinoma.

Sunitinib does not accelerate tumor growth in patients with metastatic renal cell carcinoma. Cell Rep. 2013 Feb 21; 3(2):277-81.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.